Report in English with a Dutch summary (KCE reports 63A)

KCE reports 63 Breast Cancer 43
159. Ellis, I.O., et al., Best Practice No 176: Updated recommendations for HER2 testing in the
UK.[see comment]. Journal of Clinical Pathology, 2004. 57(3): p. 233-7.
160. Ellis, I.O., et al., Best Practice No 179. Guidelines for breast needle core biopsy handling and
reporting in breast screening assessment. Journal of Clinical Pathology, 2004. 57(9): p. 897-902.
161. Pinero, A., et al., Palpable breast lesions: utility of Doppler sonography for diagnosis of
malignancy. Breast, 2003. 12(4): p. 258-63.
162. Schelfout, K., et al., Contrast-enhanced MR imaging of breast lesions and effect on treatment.
Eur J Surg Oncol, 2004. 30(5): p. 501-7.
163. Hind, D., et al., Surgery versus primary endocrine therapy for operable primary breast cancer
in elderly women (70 years plus). Cochrane Database Syst Rev, 2006(1): p. CD004272.
164. Poggi, M.M., et al., Eighteen-year results in the treatment of early breast carcinoma with
mastectomy versus breast conservation therapy: the National Cancer Institute Randomized
Trial.[see comment]. Cancer, 2003. 98(4): p. 697-702.
165. Fentiman, I.S., et al., Treatment of operable breast cancer in the elderly: a randomised clinical
trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus
tamoxifen.[see comment]. European Journal of Cancer, 2003. 39(3): p. 300-8.
166. Arriagada, R., et al., Late local recurrences in a randomised trial comparing conservative
treatment with total mastectomy in early breast cancer patients.[see comment]. Annals of
Oncology, 2003. 14(11): p. 1617-22.
167. Rudenstam, C.-M., et al., Randomized trial comparing axillary clearance versus no axillary
clearance in older patients with breast cancer: first results of International Breast Cancer Study
Group Trial 10-93.[see comment]. Journal of Clinical Oncology, 2006. 24(3): p. 337-44.
168. Kodama, H., et al., Ten-year follow-up results of a randomised controlled study comparing
level-I vs level-III axillary lymph node dissection for primary breast cancer. Br J Cancer, 2006.
95(7): p. 811-6.
169. Purushotham, A.D., et al., Morbidity after sentinel lymph node biopsy in primary breast
cancer: results from a randomized controlled trial. Journal of Clinical Oncology, 2005. 23(19): p.
4312-21.
170. Martelli, G., et al., A randomized trial comparing axillary dissection to no axillary dissection in
older patients with T1N0 breast cancer: results after 5 years of follow-up. Annals of Surgery, 2005.
242(1): p. 1-6; discussion 7-9.
171. Tominaga, T., S. Takashima, and M. Danno, Randomized clinical trial comparing level II and
level III axillary node dissection in addition to mastectomy for breast cancer. British Journal of
Surgery, 2004. 91(1): p. 38-43.
172. Ford, H.T., et al., Long-term follow-up of a randomised trial designed to determine the need
for irradiation following conservative surgery for the treatment of invasive breast cancer. Annals of
Oncology, 2006. 17(3): p. 401-8.
173. Clarke, M., et al., Effects of radiotherapy and of differences in the extent of surgery for early
breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
Lancet, 2005. 366(9503): p. 2087-106.
174. Winzer, K.J., et al., Radiation therapy after breast-conserving surgery; first results of a
randomised clinical trial in patients with low risk of recurrence. European Journal of Cancer, 2004.
40(7): p. 998-1005.
175. Vinh-Hung, V. and C. Verschraegen, Breast-conserving surgery with or without radiotherapy:
pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.[see comment].
Journal of the National Cancer Institute, 2004. 96(2): p. 115-21.
176. Van de Steene, J., et al., Adjuvant radiotherapy for breast cancer: effects of longer follow-up.
Radiotherapy & Oncology, 2004. 72(1): p. 35-43.
177. Fyles, A.W., et al., Tamoxifen with or without breast irradiation in women 50 years of age or
older with early breast cancer.[see comment]. New England Journal of Medicine, 2004. 351(10): p.
963-70.